Hospital Universitario de Guadalajara-ko ikertzaileekin lankidetzan egindako argitalpenak (53)

2022

  1. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

    Reumatologia Clinica, Vol. 18, Núm. 10, pp. 567-573

  2. Tele-Rheumatology During the COVID-19 Pandemic

    Reumatologia Clinica, Vol. 18, Núm. 3, pp. 157-163

  3. Usefulness of Rheumatology Consultancy in situ: Analysis of a Long-term Experience

    Reumatologia Clinica, Vol. 18, Núm. 8, pp. 480-485

2021

  1. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up

    Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2906-2915

  2. Dietary habits in patients with fibromyalgia: a cross-sectional study

    Clinical and experimental rheumatology, Vol. 39, Núm. 3, pp. 170-173

  3. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382

  4. Opioids in osteoarthritis

    Revista de la Sociedad Espanola del Dolor, Vol. 28, pp. 49-56

2020

  1. Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review

    Reumatologia Clinica, Vol. 16, Núm. 3, pp. 222-228

  2. Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis

    Reumatologia Clinica, Vol. 16, Núm. 4, pp. 272-281

  3. Practical Aspects of Biological Throught Levels and Antidrug Antibodies in Rheumatoid Arthritis and Spondyloarthritis

    Reumatologia Clinica, Vol. 16, Núm. 5, pp. 378-385

2019

  1. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project

    Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739

  2. Methotrexate in patients with rheumatoid arthritis in Spain: Subanalysis of the AR Excellence project

    Reumatologia Clinica, Vol. 15, Núm. 6, pp. 338-342

2018

  1. Recommendations for the use of methotrexate in psoriatic arthritis

    Reumatologia Clinica, Vol. 14, Núm. 4, pp. 183-190

  2. Recommendations for the use of parenteral methotrexate in rheumatic diseases

    Reumatologia Clinica, Vol. 14, Núm. 3, pp. 142-149

  3. Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review

    Rheumatology International, Vol. 38, Núm. 6, pp. 975-983

2017

  1. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

  2. Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate

    Reumatologia Clinica, Vol. 13, Núm. 3, pp. 127-138

2015

  1. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide

    Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294

  2. Clasificación de los fármacos para el tratamiento del dolor osteoarticular

    Tratamiento del dolor: teoría y práctica (Permanyer), pp. 307-310

  3. Clinical repercussions of introducing biological therapies: The well-controlled patient

    Reumatologia Clinica, Vol. 11, Núm. 3, pp. 131-132